DGII vs GILD · P/E 60, rev $430.2M vs P/E 18, rev $7.80B
Digi International Inc (DGII) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Digi International Inc (DGII) is a communication equipment company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Latest reported DGII revenue for 2025-09-30 was $430.2M. Net income was $40.8M. DGII currently screens at market cap $2.56B and trailing P/E 60.1.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
DGII currently screens at market cap $2.56B and trailing P/E 60.1. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the DGII and GILD stock pages for the full models.
Not investment advice.